BANK OF AMERICA CORP /DE/ - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 67 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,673,238
-37.6%
232,963
-12.2%
0.00%0.0%
Q2 2023$7,489,304
+45.0%
265,484
-11.6%
0.00%0.0%
Q1 2023$5,164,988
+6.7%
300,290
+24.9%
0.00%0.0%
Q4 2022$4,840,447
+83.0%
240,340
+96.8%
0.00%
Q3 2022$2,645,000
-69.6%
122,135
-60.5%
0.00%
-100.0%
Q2 2022$8,696,000
-33.7%
309,467
+8.9%
0.00%0.0%
Q1 2022$13,115,000
-21.0%
284,248
+44.0%
0.00%
-50.0%
Q4 2021$16,592,000
+195.2%
197,389
+134.0%
0.00%
+100.0%
Q3 2021$5,621,000
+29.1%
84,351
+3.1%
0.00%
Q2 2021$4,353,000
+10.8%
81,827
-9.6%
0.00%
Q1 2021$3,929,000
+57.4%
90,542
+88.4%
0.00%
Q4 2020$2,496,000
+155.0%
48,064
+60.6%
0.00%
Q3 2020$979,000
+20.3%
29,932
+76.7%
0.00%
Q2 2020$814,00016,9390.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 1,824,583$39,520,00014.33%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,301,771$49,857,0004.79%
Matrix Capital Management Company, LP 9,199,973$199,271,0003.81%
Integral Health Asset Management, LLC 550,000$11,913,0002.31%
Avidity Partners Management LP 4,223,100$91,472,0001.86%
Affinity Asset Advisors, LLC 170,000$3,682,0001.03%
Eventide Asset Management 1,861,000$40,309,0000.79%
Sofinnova Investments, Inc. 583,357$12,636,0000.74%
Nicholas Investment Partners, LP 158,704$3,438,0000.32%
SECTORAL ASSET MANAGEMENT INC 60,000$1,300,0000.26%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders